2017-2202 - Horizon Pharma Ireland Ltd et al. v. Actavis Laboratories UT Inc

Detail

Case Number

2017-2202

Current Status

closed

Cause of Action

N/A

Related Case(s)

1:15-cv-07742

20-88

2017-2149

2017-2153

2017-2203

2017-2206

Court

Court of Appeals for the Federal Circuit

Plaintiff(s)

Horizon Pharma Ireland Ltd

Horizon Pharma USA Inc

Hznp Ltd

Defendant(s)

Actavis Laboratories UT Inc

Judge

N/A

Filing Date

2017-06-22

Termination Date

2019-10-10

Not a member? Sign up for free!
Dockets
Text
JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [641454] [17-2149, 17-2152, 17-2153, 17-2202, 17-2203, 17-2206] [JAB] [Entered: 10/10/2019 09:51 AM]
OPINION filed for the court by Prost, Chief Judge; Newman, Circuit Judge and Reyna, Circuit Judge. Opinion concurring in part and dissenting in part filed by Circuit Judge Newman. Precedential Opinion. [641453] [17-2149, 17-2152, 17-2153, 17-2202, 17-2203, 17-2206] [JAB] [Entered: 10/10/2019 09:50 AM]
Please see the attachment for the more details
CIVIL DOCKET
Note to file: The following cases are associated:17-2149 Lead with 17-2202 Cross-Appeal. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [441303] [17-2149, 17-2202]
Appeal docketed. Received: 06/19/2017. [441301].
Timeline
filed_date
closed_date
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2018
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2019
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2020
Feb
Mar
Apr
May
Patents In Case

Not a member? Sign up for free!